GlassScriptPhysician profile
Christopher S Bartlett
NPI 1114975687
$2,284.29
in general payments reported to CMS, 2019-2025
19 companies · $926 in 2025
The $926 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.87 · 2022: $142 · 2023: $460 · 2024: $695 · 2025: $926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,980 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,980.27 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $905.93 | 2021-2025 | |
| Janssen Biotech, INC. | $553.18 | 2023-2025 | Tremfya, Stelara |
| Gilead Sciences, INC. | $396.47 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.64 | 2024-2025 | Entyvio, Eohilia |
| Vertex Pharmaceuticals Incorporated | $41.37 | 2024-2025 | |
| Madrigal Pharmaceuticals | $35.02 | 2024 | Resmetirom |
| Genzyme Corporation | $34.74 | 2023 | |
| Davol INC. | $31.97 | 2023 | Phasix Mesh |
| Phathom Pharmaceuticals, INC. | $30.30 | 2024-2025 | Voquezna |
| Merck Sharp & Dohme LLC | $24.64 | 2021 | |
| Lilly USA, LLC | $24.17 | 2025 | Omvoh |
| Kerecis Limited | $21.87 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Pacira Pharmaceuticals Incorporated | $21.17 | 2025 | Exparel |
| Ardelyx, INC. | $18.93 | 2025 | Ibsrela |
| Teleflex LLC | $17.70 | 2023 | Titan Sgs Standard Gastric Stapler |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.79 | 2025 | Wegovy |
| Celgene Corporation | $16.46 | 2023 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.26 | 2023 | Trulance |
| Nestle Healthcare Nutrition INC. | $15.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bartlett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.